CY
Live price temporarily unavailable.
Price history
Cytokinetics Inc (CYTK) is a Health Care company in the Russell 2000. Latest news and coverage below.
Recent News (8)
-
Cytokinetics to Participate in September Investor Conferences SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company management team will participate in the followin…
-
Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026 Additional Results from ACACIA-HCM Demonstrate Improvements in Cardiac Structure and Diastolic Function in Patients with Non-Obstructive HCM
-
Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine ACACIA-HCM is the First Phase 3 Clinical Trial to Successfully Demonstrate Statistically Significant Improvements Across Both Patient-Reported and Physician-Assessed Endpoints in Non-Obstructive HCM
-
Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700
Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700
-
-
Citizens raises Cytokinetics stock price target on strong launch
Citizens raises Cytokinetics stock price target on strong launch
-
Cytokinetics to Announce Second Quarter Results on August 6, 2026 SOUTH SAN FRANCISCO, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report second quarter results on August 6, 2026 at 4…
-
More Health Care stocks
- AZN AstraZeneca
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen
- BAX Baxter International